Peter Lamb, EVP, Scientific Strategy & CSO at EXELIXIS, INC. (EXEL), sold 100,000 shares at $17.26 ($1.7M) on 2020-04-06, disclosed to the SEC on 2020-04-08.
Open-market sale of $1.7M EXEL by EVP, Scientific Strategy & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.26 | 50,000 | $863K | 50.0% |
| 2 | $17.26 | 50,000 | $863K | 50.0% |
| Total | $17.26 avg | 100,000 | $1.7M | 100% |
| Filing → |
| EXEL | SELL | 2021-11-17 | $859K | — | Filing → |
| EXEL | SELL | 2021-10-15 | $2.1M | — | Filing → |
| EXEL | SELL | 2021-09-17 | $972K | — | Filing → |